SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-14-053963
Filing Date
2014-02-14
Accepted
2014-02-14 13:27:33
Documents
1
Group Members
QVT ASSOCIATES GP LLCQVT FINANCIAL GP LLCQVT FUND V LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 3 d676800dsc13ga.htm SC 13G/A 85681
  Complete submission text file 0001193125-14-053963.txt   87507
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Subject) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-52909 | Film No.: 14614044
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A